Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in URGN — UroGen Pharma Ltd.

CIK 72971 SAN FRANCISCO, CA
Back to URGN Full portfolio

Position in URGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,952,609
+$1,950,100 QoQ
Shares Held
80,234
+43.9% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 190 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. URGN ranks #79 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in URGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,952,609 80,234
2026-03-31 $1,002,509 55,757
2025-12-31 $1,970,978 84,158
2025-09-30 $2,513,080 125,969
2025-06-30 $1,690,018 123,359
2025-03-31 $2,394,246 216,478
2024-12-31 $2,359,400 221,540
2024-09-30 $2,739,884 215,739
2024-06-30 $3,621,810 215,841
2024-03-31 $3,184,200 212,280
2023-12-31 $3,286,215 219,081
2023-09-30 $3,033,626 216,533
2023-06-30 $4,425,006 427,537
2023-03-31 $3,913,509 423,540
2022-12-31 $3,451,981 389,175
2022-09-30 $3,270,908 393,138
2022-06-30 $3,199,529 390,663
2022-03-31 $2,212,269 253,992
2021-12-31 $1,625,190 170,893
2021-09-30 $2,261,228 134,437
2021-06-30 $304,117 19,916
2021-03-31 $82,847 4,253
2020-12-31 $613,057 34,021
2020-09-30 $547,217 28,368
2020-06-30 $858,824 32,880
2020-03-31 $217,897 12,214